130 related articles for article (PubMed ID: 2501941)
1. Modifications of hepatic microsomal 9-oxidation of N-2-fluorenylacetamide in response to gonadectomy and treatment of rats with phenobarbital or diethylnitrosamine.
Malejka-Giganti D; Magat WJ; Decker RW
Xenobiotica; 1989 Apr; 19(4):431-44. PubMed ID: 2501941
[TBL] [Abstract][Full Text] [Related]
2. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR
Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341
[TBL] [Abstract][Full Text] [Related]
3. Microsomal metabolism of the carcinogen, N-2-fluorenyl-acetamide, by the mammary gland and liver of female rats. II. Glucuronidation of ring- and N-hydroxylated metabolites of N-2-fluorenylacetamide.
Malejka-Giganti D; Ryzewski CN
Carcinogenesis; 1985 May; 6(5):687-92. PubMed ID: 3924428
[TBL] [Abstract][Full Text] [Related]
4. Sex hormone-mediated effects on the phase I and phase II metabolism of N-2-fluorenylacetamide. Modulation of 9-hydroxylation.
Malejka-Giganti D; Magat WJ; Decker RW
Biochem Pharmacol; 1989 Apr; 38(7):1075-82. PubMed ID: 2495797
[TBL] [Abstract][Full Text] [Related]
5. Modifications of carcinogen metabolism in hepatic microsomes of suckling young by 3-methylcholanthrene or beta-naphthoflavone administered to lactating rats.
Malejka-Giganti D; Decker RW; Ritter CL
Biochem Pharmacol; 1983 Nov; 32(22):3335-44. PubMed ID: 6316979
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute or chronic treatment of rats with N-2-fluorenylacetamide on its N-hydroxylation and on hemoproteins of hepatic microsomes.
Malejka-Giganti D; Ritter CL
Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):53-64. PubMed ID: 7394317
[TBL] [Abstract][Full Text] [Related]
7. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of disulfiram on rat mammary tumor induction by N-2-fluorenylacetamide and on its metabolic conversion to N-hydroxy-N-2-fluorenylacetamide.
Malejka-Giganti D; McIver RC; Rydell RE
J Natl Cancer Inst; 1980 Jun; 64(6):1471-7. PubMed ID: 6929383
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro metabolism of T-2 toxin by hepatic microsomes prepared from phenobarbital-induced or control rats, mice, rabbits and chickens.
Knupp CA; Swanson SP; Buck WB
Food Chem Toxicol; 1987 Nov; 25(11):859-65. PubMed ID: 3692389
[TBL] [Abstract][Full Text] [Related]
10. Microsomal metabolism of arylamides by the rat and guinea pig--I. Oxidation of N-3-fluorenylacetamide at carbon-atom-9--a major metabolic reaction.
Kaplan E; Gutmann HR; Emory TH
Biochem Pharmacol; 1978; 27(11):1581-9. PubMed ID: 697900
[No Abstract] [Full Text] [Related]
11. Additional routes in the metabolism of phenacetin.
Fischbach T; Lenk W
Xenobiotica; 1985 Feb; 15(2):149-64. PubMed ID: 4002737
[TBL] [Abstract][Full Text] [Related]
12. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
Katayama S; Ohmori T; Maeura Y; Croci T; Williams GM
J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
[TBL] [Abstract][Full Text] [Related]
13. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats.
Suchar LA; Chang RL; Thomas PE; Rosen RT; Lech J; Conney AH
Endocrinology; 1996 Feb; 137(2):663-76. PubMed ID: 8593816
[TBL] [Abstract][Full Text] [Related]
14. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
Malejka-Giganti D; Rydell RE; Gutmann HR
Cancer Res; 1977 Jan; 37(1):111-7. PubMed ID: 830400
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 2-acetylaminofluorene. I. Metabolism in vitro of 2-acetylaminofluorene and 2-acetylaminofluoren-9-one by hepatic enzymes.
Lenk W; Rosenbauer-Thilmann R
Xenobiotica; 1993 Mar; 23(3):241-57. PubMed ID: 8498087
[TBL] [Abstract][Full Text] [Related]
16. Influences of different polychlorinated biphenyls on cytocidal, mitoinhibitory, and nodule-selecting activities of N-2-fluorenylacetamide in rat liver.
Hayes MA; Roberts E; Safe SH; Farber E; Cameron RG
J Natl Cancer Inst; 1986 Apr; 76(4):683-91. PubMed ID: 2870208
[TBL] [Abstract][Full Text] [Related]
17. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography.
Imaoka S; Inoue K; Funae Y
Arch Biochem Biophys; 1988 Aug; 265(1):159-70. PubMed ID: 3415241
[TBL] [Abstract][Full Text] [Related]
18. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
Wroblewski VJ; Gessner T; Olson JR
Biochem Pharmacol; 1988 Apr; 37(8):1509-17. PubMed ID: 3358781
[TBL] [Abstract][Full Text] [Related]
19. Effect of the structural isomer N-3-fluorenylacetamide on microsomal binding and hydroxylation of the carcinogen N-2-fluorenylacetamide.
Chow YM; Gutmann HR; Kaplan E
Biochem Pharmacol; 1981 Jun; 30(11):1253-61. PubMed ID: 7271824
[No Abstract] [Full Text] [Related]
20. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
Jeffery EH; Mannering GJ
Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
